Publication | Closed Access

Antitumor effects of cytoplasmic delivery of an innate adjuvant receptor ligand, poly(I:C), on human breast cancer

Breast OncologyCytoplasmic DeliveryMedicinePolymer-drug ConjugateImmunologyHuman Breast CancerBreast CancerAntitumor EffectsAnti-cancer AgentTumor TargetingImmunotherapyPharmacologyTumor MicroenvironmentTumor Biology